Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Microbial-Derived D-lactate Modulates Inflammation and Contributes to Insulin Resistance
EF 2020-21
Résumé
Obesity-induced inflammation promotes type 2 diabetes and non-alcoholic fatty liver disease, which are associated with changes in the intestinal microbiome. Recent evidence showed that gut microbiota regulate blood glucose homeostasis via hepatic gluconeogenesis, but the bacterial metabolite that acted as a substrate for liver metabolism was unknown. We propose that bacterial D-lactate is a key substrate for liver glycogen, fat, and blood glucose. The importance of D-lactate appears long forgotten and has led to a dearth of knowledge of the metabolism of D-lactate and its role in metabolic disease. This is a key knowledge gap because people and rodent models with diabetes both have higher levels of blood and urine D-lactate. D-lactate derived from bacteria has not been investigated in T2D or other metabolic diseases. D-lactate-induced inflammation can promote lipogenesis, thereby promoting hepatic lipid accumulation. We will measure the genesis of liver lipids by L vs D-lactate in hepatocytes. We will test how L vs D-lactate alters macrophage and hepatocyte interactions that link inflammation to lipogenesis. In primary hepatocytes, we will directly compare L and D-lactate at concentrations seen in human and mouse blood as substrates for de novo lipogenesis. In bone marrow-derived macrophages, we will compare the effect of L and D-lactate with LPS on inflammatory gene expression and cytokine secretion. Further, we will use transwell co-culture of primary macrophages and primary hepatocytes to measure how this immune-metabolic cell interaction affects de novo lipogenesis in primary mouse hepatocytes. This research may lead to the identification of a new pathway and therapy for NAFLD that limits D-lactate-related inflammation and de novo lipogenesis in the liver.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449808
Name
Singh Anita
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Microbial-Derived D-lactate Modulates Inflammation and Contributes to Insulin Resistance
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cytokines; Diabetes; Hepatocytes; Immunometabolism; Inflammation; Liver; Macrophages; Metabolism
Abstract
Obesity-induced inflammation promotes type 2 diabetes and non-alcoholic fatty liver disease, which are associated with changes in the intestinal microbiome. Recent evidence showed that gut microbiota regulate blood glucose homeostasis via hepatic gluconeogenesis, but the bacterial metabolite that acted as a substrate for liver metabolism was unknown. We propose that bacterial D-lactate is a key substrate for liver glycogen, fat, and blood glucose. The importance of D-lactate appears long forgotten and has led to a dearth of knowledge of the metabolism of D-lactate and its role in metabolic disease. This is a key knowledge gap because people and rodent models with diabetes both have higher levels of blood and urine D-lactate. D-lactate derived from bacteria has not been investigated in T2D or other metabolic diseases. D-lactate-induced inflammation can promote lipogenesis, thereby promoting hepatic lipid accumulation. We will measure the genesis of liver lipids by L vs D-lactate in hepatocytes. We will test how L vs D-lactate alters macrophage and hepatocyte interactions that link inflammation to lipogenesis. In primary hepatocytes, we will directly compare L and D-lactate at concentrations seen in human and mouse blood as substrates for de novo lipogenesis. In bone marrow-derived macrophages, we will compare the effect of L and D-lactate with LPS on inflammatory gene expression and cytokine secretion. Further, we will use transwell co-culture of primary macrophages and primary hepatocytes to measure how this immune-metabolic cell interaction affects de novo lipogenesis in primary mouse hepatocytes. This research may lead to the identification of a new pathway and therapy for NAFLD that limits D-lactate-related inflammation and de novo lipogenesis in the liver.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Singh, Anita
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~